Epithelioid Hemangioendothelioma
📧 Sign up to get email alerts when something new happens for Epithelioid Hemangioendothelioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)
Registry-based clinical trial update for the Epithelioid Hemangioendothelioma Registry within EURACAN, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma [Phase 2]
Phase II trial of Nab-Sirolimus for epithelioid hemangioendothelioma; the study (SARC046) is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group [NA]
An ongoing clinical trial under the MIRAS project aims to perform multimodal immune characterization of rare soft tissue sarcomas and relate…
-
CLINICAL_TRIALS trial_result · 2024-11-26Clinical Trial Update: Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery [Phase 2]
A Phase 2 trial of trametinib for epithelioid hemangioendothelioma (locally advanced, metastatic, or unresectable) has completed with result…
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors [Phase 1]
Phase 1 study of an oral TEAD inhibitor from Ikena Oncology in adults with advanced solid tumors has been terminated. The trial included pat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE) [Phase 2]
Phase 2 clinical trial of eribulin in angiosarcoma and epithelioid hemangioendothelioma has posted results.
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors [Phase 1]
BridGene Biosciences' BGC515 capsules are in a Phase 1 trial for advanced solid tumors, including malignant mesothelioma and epithelioid hem…